| Literature DB >> 28253835 |
M K de Bie1, M S Buiten1, J I Rotmans2, M Hogenbirk3, M J Schalij1, T J Rabelink1, J W Jukema4.
Abstract
BACKGROUND: Coronary artery disease (CAD) is common in asymptomatic chronic dialysis patients and plays an important role in their poor survival. Early identification of these high-risk patients could improve treatment and reduce mortality. Abdominal aortic calcification (AAC) has previously been associated with CAD in autopsy studies. Since the AAC can be quantified easily using a lateral lumbar X-ray we hypothesized that the extent of AAC as assessed on a lateral lumbar X-ray might be predictive of the presence of significant CAD in dialysis patients.Entities:
Keywords: Abominal aortic calcification; Coronary Artery disease; Dialysis; Vascular calcification
Mesh:
Year: 2017 PMID: 28253835 PMCID: PMC5335756 DOI: 10.1186/s12882-017-0480-2
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Fig. 1Grading of abdominal aortic calcification. For all segments both the anterior and posterior wall are graded for the extent of vascular calcification. Grading: 0 points: No calcific deposits; 1 point: less than 1/3 of the wall calcified; 2 points : between 1/3 and 2/3 of the wall affected; 3 points : more than 2/3 of the wall affected. The right panel shows an example of this calculation
Baseline characteristics
| All ( | No CAD ( | CAD ( | |
|---|---|---|---|
| Age, yrs | 67 ± 7 | 65 ± 7 | 69 ± 7* |
| Male gender, nr.(%) | 64 (71%) | 27 (61%) | 37 (80%) |
| Hemodialysis, nr.(%) | 62 (69%) | 29 (66%) | 33 (72%) |
| Dialysis Vintage, months | 18 [9, 29] | 17 [9, 33] | 18 [8, 25] |
| BMI | 26.8 ± 4.4 | 26.8 ± 4.5 | 26.8 ± 4.3 |
| Hypertension, nr (%) | 70 (77%) | 32 (73%) | 38 (83%) |
| Diabetes, nr (%) | 26 (29%) | 12 (27%) | 14 (30%) |
| History of smoking, nr (%) | 60 (67%) | 28 (64%) | 32 (70%) |
| Beta-Blocker, nr (%) | 45 (50%) | 23 (52%) | 22 (48%) |
| ACEi/ARB, nr (%) | 48 (53%) | 21 (48%) | 27 (59%) |
| Statin, nr (%) | 45 (50%) | 21 (48%) | 24 (52%) |
| Troponin I (ng/L) | 12 [7–22] | 12 [6–24] | 13 [7–17] |
| Troponin T (ng/L) | 48 [32–75] | 42 [29–71] | 55 [35–81] |
| LV Ejection Fraction (%) | 54% ± 6% | 54% ± 7% | 53% ± 6% |
| LVMi (g/m2) | 125 ± 40 | 128 ± 45 | 122 ± 34 |
| CACS | 690 [133, 2085] | 279 [20, 1691] | 912 [441, 2217]* |
| AAC-score | 8.2 ± 5.1 | 6.3 ± 4.6 | 10.1 ± 4.9* |
CAD coronary artery disease, BMI body mass index, ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, LV left ventricular; LVMi left ventricular mass indexed for body surface area, CACS coronary artery calcification score, AAC abdominal aortic calcification; * = p <0.05
Uni- and multivariate predictors for the presence of CAD
| Univariate | Multivariate | |
|---|---|---|
| Age | 1.06 (1.00–1.13), | 1.02 (0.95–1.09), |
| Male gender | 2.59 (1.00–6.68), | 2.73 (0.95–7.82), |
| Hemodialysis | 1.31 (0.54–3.20), | |
| Dialysis vintage | 1.0 (0.99–1.00), | |
| AACscore (per point) | 1.19 (1.07–1.30), | 1.18 (1.06–1.32), |
| Diabetes | 1.17 (0.47–2.90), | |
| History of smoking | 1.31 (0.54–3.14), | |
| Hypertension | 1.78 (0.65–4.89), | |
| BMI | 1.0 (0.91–1.10), |
AAC abdominal aortic calcification, BMI body mass index
Presence of significant CAD using an AACscore cutoff of 6.5 points
| CAD | No CAD | ||
|---|---|---|---|
| AACscore ≥6.5 | 39 | 19 |
|
| AACscore <6.5 | 7 | 25 |
|
|
|
|
CAD coronary artery disease, AACscore abdominal aortic calcification score
Fig. 2ROC-analysis of AAC-score